Vaccine News: Breaking Vaccine News, Comments and Articles. - Page: 4

Alliance for Cancer Gene Therapy to Host Inaugural Foundation Symposium at the 16th Annual American Society of Gene and Cell Therapy Meeting

Renowned Scientists, Physicians, and Researchers to Showcase Breakthrough Cell and Gene Therapies for Cancer Alliance for Cancer Gene Therapy, Inc. (ACGT), www.acgtfoundation.org, https://twitter.com/acgtfoundation, and

Cobra Biologics and Vaccibody sign DNA manufacturing agreement

Vaccine candidate against HPV-induced malignancies, such as precancerous lesions found in cervical cancer

India-developed rotavirus vaccine demonstrates strong efficacy

In a public-private partnership, the Indian government's Department of Biotechnology (DBT) and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. Data from the trial,...

Monoclonal antibodies in drug and vaccine development

Monoclonal antibodies (mAbs) are remarkably versatile protein molecules with numerous applications in human health. More than 30 mAb therapeutics have been approved for marketing and approximately 360 mAbs are currently in clinical studies, with 30 i...

Bipolar Risk Fourfold Higher When Pregnant Mother Exposed To Flu

Michael Harper for redOrbit.com – Your Universe Online Research has found long-term disorders in adulthood may begin at pregnancy. A National Institutes of Health (NIH) funded study has found pregnant women who come in contact with influenza increase the risk their child will later develop bipolar disorder by fourfold. Other studies have also found that a pregnant woman’s exposure to the flu...

Anti-Cocaine vaccine successfully tested in primates

A novel anti-cocaine vaccine has been successfully tested in primates, bringing researchers closer to launching clinical trials with the vaccine in humans. The research was [...]

Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study

BLUE BELL, Pa., May 14, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that in a preclinical study of Inovio's SynCon® DNA vaccine against Ebola and Marburg filoviruses, labeled "Category A" bioterrorism agents by the U.S. government, the vaccine induced strong and broad immune responses and demonstrated 100% protection against death following a challen...

Results of the ROTAVAC Rotavirus Vaccine Study in India

We congratulate the Program for Appropriate Technology in Health (PATH), Bharat Biotech International, Ltd., and the scientists, government and people of India on the important results from the ROTAVAC rotavirus vaccine study.

Effective vaccination against borreliosis possible

"Borreliosis" or "Lyme disease" is caused by the bacterium "Borrelia burgdorferi". In Austria approximately 16,000 people fall ill with borreliosis annually following a tick bite. Roughly every fifth tick in Austria carries the pathogen. Borreliosis...

India announces low-cost rotavirus vaccine (Update)

The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world.

India unveils vacccine for deadly diarrhoea virus

Scientists unveiled Tuesday an affordable vaccine against a deadly diarrhoea-causing virus that kills some 100,000 children in India every year.

Reshaping research framework to enhance the ability to generate innovative drugs

Tokyo, Japan, May 14, 2013 - Astellas Pharma Inc. (Tokyo：4503, President and CEO: Yoshihiko Hatanaka, hereinafter called “Astellas”) today announced plans to reshape its research framework by introducing new initiatives to further enh...

Inovio Pharmaceuticals: Why Best Therapeutic Vaccine Award In 2013?

By Iggy Igette: Inovio Biomedical (INO) is focused on the development of multiple DNA-based vaccines through its electroporation-delivery platform. The company has shown, through multiple pre-clinical and Phase I studies, that its delivery system enhances the potency of vaccines to not only prevent but also treat both cancers and infectious diseases.Current vaccination techniques inject either a w...

Sinovac Presents at the UBS Global Healthcare Conference in May 2013

BEIJING, May 14, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the UBS Global Healthcare Conference in New York City. The Sinovac management team inclusive of Nan Wang, Vice President, and Helen Yang, Director, Investor Relations and International Business Develo...

India's DBT, Bharat Biotech announce positive Phase III clinical trial results of rotavirus vaccine

The Government of India's Department of Biotechnology and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India.

Prevalence of Flu and Use of Flu Shots Last Winter Fairly Typical of Last Decade

NEW YORK, May 14, 2013 /PRNewswire/ -- Last winter's flu season was fairly typical of other winters over the last decade, with the prevalence of the flu and the number of people who had flu shots both fairly close to the averages for that time period.  The effectiveness of flu vaccines also seems to have been fairly typical.  (Logo:  http://photos.prnewswire.com/prnh/20100517...

[Comment] Diarrhoea in children: identifying the cause and burden

The past decade has seen a substantial reduction in deaths from diarrhoea, yet diarrhoea still accounts for nearly 10% of the 7·6 million deaths in children younger than 5 years. Documenting the aetiology of diarrhoea is important to guide vaccine d...

[Articles] Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

Interventions targeting five pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can substantially reduce the burden of moderate-to-severe diarrhoea. New methods and accelerated implementation of existing interv...

Canadian Healthcare Innovation, the MyMedRec App Goes Global

OTTAWA, ONTARIO -- (Marketwired) -- 05/14/13 -- MyMedRec, one of Canada's top free iPhone apps to help people and their families keep track of medication use and immunization history, is now available internationally. MyMedRec allows users to keep information on their medications and vaccines at their fingertips, ready to share with their healthcare providers. The personal electronic medication...

New Global Surveillance Tool Detects And Monitors Public Concerns About Vaccines In Real Time And Could Help Boost Vaccine Uptake

Scientists have developed a global media surveillance system that enables them to look for, and systematically monitor, up-to-the-minute public concerns and rumours about vaccines originating from 144 countries. The application could help public heal...

Infants Born To Vaccinated Mothers May Lose Initial Measles Immunity Sooner Than Those Born To Unvaccinated Mothers

Dutch study findings support earlier vaccination of newborns at high risk for measles A new Dutch study suggests that infants born to mothers who received the measles-mumps-rubella (MMR) vaccine lose their initial immunity to measles--acquired from t...

Victims Committee Requests Japan Investigation Of Merck, GSK Cervical Cancer Vaccines

Japan’s National Cervical Cancer Vaccine Victim Liaison Committee, a group that supports women suffering from side effects of cervical cancer vaccines that became a routine vaccination in April 2013, has filed a request to to investigate side effec...

Potential Lyme Disease Vaccine Shows Promise

A vaccine for Lyme disease may be on its way, following a promising phase 1/2 clinical trial from investigators at the Stony Brook University School of Medicine and Brookhaven National Laboratory. The finding was published online in The Lancet Infect...

Human Testing Of Anti-Cocaine Vaccine Likely Within A Year

Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. Their study, published online by the journal Neuropsychopharmacology, used a...

Rotavirus vaccine developed in India demonstrates strong efficacy

(PATH) The Government of India's Department of Biotechnology and Bharat Biotech announced positive results from a Phase III clinical trial of a rotavirus vaccine developed and manufactured in India. Data from the trial, presented today at the Interna...